AKT1 and colonic neoplasm: In PT colon cancer cells, a single treatment with butyrate causes a decrease in phospho-Akt and results in an increase in phospho-AMPKα and a decrease in phospho-mTOR levels, inducing cancer-suppressing autophagy and anticancer effects.